News & Insights

While advances in diagnostics and treatment have made significant progress, one critical barrier to seeking medical attention remains the: stigma around this infectious disease.

AJ Vaccines is proud to be a commercial partner in the development of the world's first vaccine against Hepatitis C - a breakthrough with the potential to save millions of lives globally.

Read the news from Innovation Fund Denmark.

By Myassa Kjaerem,

Senior Global Medical Advisor, MD. PhD:

With my background in oncology research, I recognize the complexity of cancer and the profound impact the disease has on patients and their loved ones.

Copenhagen, January 29th, 2025 – AJ Vaccines today announces the decision to phase out its Polio (Picovax) production as part of its strategy to ensure a sustainable and competitive future. This decision was made in response to unfavorable market conditions and significant financial challenges associated with Polio vaccine production.